Lv2
130 积分 2025-07-17 加入
Frequency of Key Pharmacogenes CYP2C9 , CYP2C19 , CYP2D6 , and SLCO1B1 in the Yogyakarta Population: Implications for Precision Prescribing in Indonesia
11小时前
待确认
Impact of SLCO1B1 and ABCB1 variants on statin efficacy and toxicity in a Tunisian population
22天前
已关闭
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
22天前
已关闭
Study on the relationship between SLCO1B1 and ApoE gene polymorphisms and the risk of coronary heart disease in the Mongolian population
1个月前
已完结
Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis
2个月前
已完结
[Study of the urinary mucoproteins in renal lithiasis. I. By the determination of hexosamines]
3个月前
已关闭
Utilizing Pharmacogenomic Data for a Safer Use of Statins among theEmirati Population
3个月前
已完结
Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote
4个月前
已完结
Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder
4个月前
已完结
Low-Density Lipoprotein Cholesterol Time in Target Range and Clinical Outcomes in the General Population
5个月前
已完结
皖公网安备34019202002308
